Fact-checked by Grok 2 weeks ago

Neurodevelopmental disorder

Neurodevelopmental disorders are a group of behavioral and cognitive conditions that arise during the developmental period, involving significant difficulties in acquiring and executing specific intellectual, motor, language, or social functions.^[1] These disorders typically manifest early in life, often before a child enters grade school, and can lead to impairments in personal, social, academic, or occupational functioning.^[2] According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), neurodevelopmental disorders encompass a heterogeneous set of conditions with onset in the developmental period, characterized by deviations in the brain's growth and maturation that result in atypical cognitive, motor, or social development.^[3] Common examples include autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), intellectual disability, and communication disorders.^[2] ASD involves persistent deficits in social communication and interaction, along with restricted, repetitive patterns of behavior, interests, or activities.^[1] ADHD is marked by a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development.^[1] Intellectual disability refers to significant limitations in intellectual functioning and adaptive behavior across conceptual, social, and practical domains.^[1] These disorders frequently co-occur, with comorbidities such as anxiety, epilepsy, or sleep disturbances complicating diagnosis and management.^[4] The causes of neurodevelopmental disorders are multifaceted, involving genetic factors, prenatal and perinatal complications, environmental exposures, and infections.^[5] For instance, genetic mutations and metabolic issues like thyroid hormone receptor deficiency contribute to their etiopathogenesis, while environmental toxins and maternal health during pregnancy increase risk.^[6] Prevalence estimates indicate that approximately 1 in 6 children aged 3–17 years in the United States has one or more developmental disabilities, including neurodevelopmental types, affecting all racial, ethnic, and socioeconomic groups; globally, neurodevelopmental disorders affect approximately 15% of children and adolescents (as of 2023).^[5]^[7] Early identification and interventions, such as behavioral therapies, speech and occupational therapy, and sometimes medications, are crucial for improving outcomes and quality of life.^[1]

Overview

Definition

Neurodevelopmental disorders are a group of conditions originating from disruptions in neural development during the early stages of life, typically becoming evident in infancy or childhood and impacting key domains such as cognition, social interaction, motor skills, or behavior.^[8] These disorders are characterized by onset in the developmental period, often before school entry, and result in significant impairments in personal, social, academic, or occupational functioning.^[8] According to the ICD-11, they encompass behavioral and cognitive disorders that arise during development and involve substantial difficulties in the acquisition, execution, or maintenance of age-appropriate intellectual, motor, language, or social functions.^[1] A defining feature of neurodevelopmental disorders is their early emergence, generally within the developmental period spanning birth to approximately age 18-22 years, with symptoms persisting lifelong and requiring ongoing support to mitigate functional limitations.^[9] This lifelong trajectory distinguishes them as conditions rooted in atypical brain maturation rather than acute events, leading to heterogeneous presentations that affect adaptive behaviors across contexts.^[2] The terminology and classification of these disorders have undergone significant evolution, beginning in the early 20th century with concepts like "mental retardation," which broadly encompassed intellectual impairments and was used in earlier diagnostic manuals such as DSM-IV. By the mid-20th century, the focus shifted toward biological underpinnings, culminating in the DSM-5 (2013), where "neurodevelopmental disorders" became a unified category emphasizing developmental origins, and "mental retardation" was replaced with "intellectual developmental disorder" to align with contemporary, person-centered language. The ICD-11, effective from 2022, further refined this framework by integrating neurodevelopmental disorders as a primary chapter, highlighting their shared etiologies in early brain development.^[2] In contrast to neurodegenerative disorders, which feature progressive loss of neuronal structure and function usually beginning in adulthood, neurodevelopmental disorders arise from initial deviations in brain maturation without ongoing degeneration.^[10] This distinction underscores their non-progressive nature, where challenges stem from foundational developmental disruptions rather than later-life deterioration.^[10]

Epidemiology

Neurodevelopmental disorders collectively affect an estimated 10-15% of children worldwide, encompassing a range of conditions that impair cognitive, social, emotional, or motor functioning during early development.^[11] According to a 2023 WHO-UNICEF report, approximately 317 million children and young people were affected by health conditions contributing to developmental disabilities, including neurodevelopmental types, in 2019—representing about 14% of those under age 18. Specific disorders within this category show varying prevalence rates; for instance, autism spectrum disorder (ASD) has a global prevalence of approximately 1 in 127 children (0.8%), though U.S. surveillance data indicate higher rates of about 3.2% (1 in 31) among 8-year-olds as of 2022.^[12]^[13] Attention-deficit/hyperactivity disorder (ADHD) affects around 8% of children globally, with U.S. estimates reaching 11.4% for ever-diagnosed cases among those aged 3-17 years as of 2022.^[14]^[15] Intellectual disabilities occur in 1-3% of the population globally, with U.S. data suggesting about 1% among adults aged 21-41.^[16]^[17] Demographic patterns reveal notable variations in prevalence and diagnosis. Males are disproportionately affected, with a sex ratio of approximately 4:1 for ASD and similar imbalances for ADHD, potentially due to genetic and diagnostic factors.^[18] Urban-rural disparities exist, as children in rural areas face barriers to diagnosis and services, leading to lower reported rates compared to urban settings where access to specialists is greater.^[19] Recent studies also indicate increases in diagnoses attributed to improved screening and awareness, as well as pandemic-related disruptions in early intervention. Socioeconomic factors significantly influence risk and outcomes, with poverty elevating the odds of neurodevelopmental disorders by 2-3 times through mechanisms like nutritional deficits and chronic stress.^[20] In low-income countries, underdiagnosis is prevalent due to limited healthcare infrastructure and cultural barriers, resulting in reported rates as low as 0.2-1%, far below global averages.^[21] Over time, diagnosis trends reflect growing recognition rather than true incidence increases. ADHD diagnoses have roughly doubled since 2000, rising from about 6% to over 10% in U.S. children by 2022, primarily due to enhanced awareness, broader diagnostic criteria, and reduced stigma.^[22]^[23] Similar patterns are observed for other neurodevelopmental disorders, underscoring the role of improved detection in shaping epidemiological data.^[24]

Classification

Intellectual developmental disorders

Intellectual developmental disorders, as defined in the ICD-11 under code 6A00, are a group of etiologically diverse conditions originating during the developmental period and characterized by significantly subaverage intellectual functioning and adaptive behavior, each approximately two or more standard deviations below what is considered normal for the person's age, gender, and sociocultural background. These impairments limit the individual's ability to learn academic skills and adapt to contextual demands in home, school, and community settings.^[25] Intellectual functioning encompasses reasoning, problem-solving, planning, abstract thinking, judgment, academic learning, and learning from experience, while adaptive behavior includes conceptual, social, and practical skills necessary for daily functioning.^[26] The disorders are subclassified by severity in ICD-11: mild (6A00.0, approximately two standard deviations below the mean, corresponding to IQ 50-70), moderate (6A00.1, three standard deviations below, IQ 35-50), severe (6A00.2, four standard deviations below, IQ 20-35), and profound (6A00.3, more than four standard deviations below, IQ below 20-25). Individuals with mild impairment can often achieve academic skills up to about sixth-grade level, hold jobs in supported settings, and live semi-independently, whereas those with profound impairment require lifelong support for basic needs and exhibit very limited communication. Globally, intellectual developmental disorders affect approximately 1-2% of the population, with higher rates in low- and middle-income countries due to factors like prenatal care access.^[27] Representative examples include Down syndrome, a chromosomal condition caused by trisomy 21 with a birth prevalence of about 1 in 700, typically resulting in mild to moderate intellectual impairment alongside physical features like hypotonia. Another is fragile X syndrome, the most common inherited cause of intellectual disability, resulting from a mutation in the FMR1 gene on the X chromosome and affecting about 1 in 4,000 males and 1 in 8,000 females, often leading to moderate impairment with associated behavioral challenges.^[28] Diagnosis requires comprehensive assessment, including standardized IQ tests such as the Wechsler Intelligence Scale for Children (WISC) or Wechsler Adult Intelligence Scale (WAIS) to quantify intellectual functioning below 70-75, combined with evaluations of adaptive behavior using tools like the Vineland Adaptive Behavior Scales (VABS) to confirm deficits across multiple domains. These assessments must account for cultural and linguistic factors to ensure validity, with onset confirmed before age 18 or during the developmental period.^[29] Intellectual developmental disorders frequently co-occur with autism spectrum disorder, affecting up to 40% of cases.

Communication disorders

Communication disorders encompass a group of neurodevelopmental conditions characterized by persistent difficulties in the acquisition and use of language and communication skills, impacting spoken, written, sign language, or other modalities, without being attributable to sensory impairments or neurological damage.^[30] These disorders manifest early in development and can significantly affect academic, social, and occupational functioning if unaddressed.^[31] Unlike global intellectual impairments, communication disorders specifically target language-related processes, though they may co-occur with other neurodevelopmental conditions.^[32] The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) delineates four primary subtypes of communication disorders. Language disorder involves deficits in comprehension or production of spoken, written, or sign language, exceeding what is expected for the individual's age, with difficulties in vocabulary, grammar, discourse, or narrative skills persisting across multiple contexts. Speech sound disorder is marked by persistent challenges in articulation or phonology, resulting in speech that is unintelligible or atypical for age, often involving substitutions, omissions, or distortions of sounds. Childhood-onset fluency disorder, commonly known as stuttering, features disruptions in speech flow, such as repetitions, prolongations, or blocks, beginning in early childhood and causing distress or functional limitations. Social (pragmatic) communication disorder entails impairments in the social use of verbal and nonverbal communication, including challenges with conversational turn-taking, topic maintenance, understanding implied meanings, and adapting language to social contexts, without the restricted interests or repetitive behaviors seen in autism spectrum disorder.^[33] Prevalence estimates indicate that language disorders affect 7-8% of children in the general population, with developmental language disorder of unknown origin occurring in approximately 7.58% based on standardized assessments of language ability relative to nonverbal IQ.^[34] Social (pragmatic) communication disorder shows a similar rate, with about 8% of children in early primary school scoring below the 10th percentile on social-pragmatic measures, though it is distinct from autism and often underdiagnosed due to overlapping features.^[35] These disorders typically emerge in early childhood, with symptoms becoming apparent by ages 4-5 as language demands increase, though delays may be noted earlier during routine developmental screenings.^[36] Early interventions, such as speech-language therapy focusing on targeted skill-building, yield positive outcomes in 60-70% of cases, with improvements in expressive and receptive language persisting into school age when initiated before age 5.^[37] Communication disorders are also associated with attention-deficit/hyperactivity disorder (ADHD), where children with ADHD exhibit higher rates of pragmatic language difficulties.^[38] Diagnosis relies on comprehensive assessments, including standardized tools like the Clinical Evaluation of Language Fundamentals (CELF-5), which evaluates core language skills such as semantics, syntax, and pragmatics through subtests of receptive and expressive abilities, helping to confirm deficits and guide intervention planning.

Autism spectrum disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by persistent deficits in social communication and social interaction across multiple contexts, as well as restricted, repetitive patterns of behavior, interests, or activities. According to the DSM-5 criteria, these social communication deficits include challenges in social-emotional reciprocity, nonverbal communicative behaviors, and developing, maintaining, and understanding relationships. The restricted and repetitive behaviors encompass stereotyped or repetitive motor movements, insistence on sameness, highly restricted interests, and hyper- or hyporeactivity to sensory input. Symptoms must be present in early developmental periods, cause clinically significant impairment, and not be better explained by intellectual developmental disorder or global developmental delay, with severity rated on a three-level scale based on the level of support required: level 1 (requiring support), level 2 (requiring substantial support), and level 3 (requiring very substantial support).^[39] The disorder exists on a spectrum, ranging from individuals with high-functioning presentations—formerly diagnosed as Asperger's disorder, who may have average or above-average intellectual abilities but struggle with social nuances—to those with profound needs involving severe communication impairments and intellectual disability. ASD often co-occurs with intellectual developmental disorder, though the two are distinct classifications. Recent epidemiological data indicate a prevalence of approximately 1 in 31 (3.2%) among 8-year-old children in the United States, based on surveillance from multiple sites, reflecting increased identification efforts and potential rises in incidence. Core features beyond the diagnostic criteria frequently include sensory sensitivities, such as hyperreactivity to sounds, lights, or textures affecting over 96% of individuals, and executive function issues like difficulties with planning, flexibility, and impulse control, which exacerbate daily challenges.^[40]^[41]^[42]^[43] Genetic factors play a significant role in ASD etiology, with mutations in genes like SHANK3 implicated in 1-2% of cases, often leading to synaptic dysfunction and associated intellectual disability. These mutations highlight the disorder's heterogeneous genetic basis, contributing to the variable presentation across the spectrum. Historically, the DSM-5, published in 2013, shifted from the DSM-IV's separate diagnoses (autistic disorder, Asperger's disorder, pervasive developmental disorder not otherwise specified, and childhood disintegrative disorder) to a unified ASD category, aiming to better capture the dimensional nature of symptoms and reduce diagnostic silos while incorporating sensory features into the criteria. This change emphasized the continuum of severity and support needs, facilitating more consistent identification and intervention.^[44]^[45]

Attention-deficit/hyperactivity disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that are inconsistent with an individual's developmental level and cause significant impairment in social, academic, or occupational functioning.^[46] Inattention manifests as difficulty sustaining focus, organizing tasks, or following through on instructions, while hyperactivity involves excessive motor activity or fidgeting inappropriate to the setting, and impulsivity includes interrupting others or making hasty decisions without forethought.^[47] These symptoms must persist for at least six months and be present in multiple settings, such as home and school, to meet diagnostic criteria. The DSM-5 classifies ADHD into three presentations based on the predominant symptom domains: predominantly inattentive (characterized mainly by attention difficulties without significant hyperactivity), predominantly hyperactive-impulsive (marked by excessive movement and impulsivity with less inattention), and combined (featuring substantial symptoms from both domains).^[47] Diagnosis requires evidence of symptoms onset before age 12 years, with at least six symptoms (or five for adolescents aged 17 and older) in the relevant domain causing impairment across contexts. This classification emphasizes the heterogeneity of ADHD, allowing for tailored assessment and intervention.^[48] Globally, ADHD affects approximately 5-7% of children and 2.5% of adults, with a higher prevalence in males at a ratio of about 2:1 compared to females.^[49] These estimates derive from meta-analyses of epidemiological studies, highlighting ADHD as one of the most common neurodevelopmental disorders in youth, though persistence into adulthood varies based on symptom severity and support.^[14] The neurobiological basis of ADHD involves dysregulation in the dopamine and norepinephrine neurotransmitter systems, which are critical for executive functions like attention and impulse control.^[50] Recent 2024 neuroimaging studies have linked these disruptions to structural and functional differences in the prefrontal cortex, including reduced volume and altered connectivity that impair cognitive regulation.^[51] Diagnosis typically relies on standardized tools such as the Vanderbilt ADHD Diagnostic Rating Scales, which assess symptom frequency and impairment through parent and teacher reports to confirm onset before age 12 and cross-setting consistency.^[52] These scales screen for inattentive and hyperactive-impulsive symptoms alongside performance impacts, facilitating comprehensive evaluation.^[53] ADHD often overlaps with specific learning disorders in about 20-60% of cases, complicating academic outcomes.

Motor disorders

Motor disorders are a category of neurodevelopmental disorders characterized by impairments in the acquisition and execution of motor skills, often manifesting in early childhood and persisting into later life. According to the DSM-5, this group includes developmental coordination disorder (DCD, also known as clumsy child syndrome), stereotypic movement disorder, and tic disorders such as Tourette's disorder.^[54] These conditions arise from disruptions in the neural processes underlying motor control and coordination, leading to functional challenges without an identifiable underlying neurological disease in most cases.^[54] Developmental coordination disorder involves significant delays in the development of motor coordination that interfere with academic, recreational, or daily activities, such as handwriting, sports participation, or self-care tasks.^[54] Children with DCD often exhibit delayed motor milestones, poor balance, clumsiness, and difficulties with fine and gross motor skills, with prevalence estimated at 5-6% in school-aged children.^[55]^[56] Stereotypic movement disorder features repetitive, seemingly driven motor behaviors—such as body rocking, hand flapping, or head banging—that are not better explained by another condition and cause distress or impairment.^[54] Tic disorders encompass sudden, rapid, recurrent, nonrhythmic motor movements or vocalizations, with Tourette's disorder requiring both motor and vocal tics persisting for over a year; the prevalence of chronic tic disorders, including Tourette's, is approximately 1% among children.^[54]^[57] Diagnosis of these disorders emphasizes functional impairment, as outlined in the ICD-11, which aligns with DSM-5 criteria by requiring that motor difficulties significantly affect daily functioning and are not attributable to intellectual disability or other medical conditions. The ICD-11, in its 2025 update, continues to highlight the developmental onset and persistence of these impairments as key diagnostic features.^[58] Differentiation from neurological conditions like cerebral palsy relies on the absence of perinatal brain injury or other acquired causes in motor disorders; DCD and related conditions have a purely developmental trajectory without structural brain damage.^[55] Comorbidities, such as with attention-deficit/hyperactivity disorder, are common and can exacerbate motor challenges.^[59]

Specific learning disorders

Specific learning disorders, also known as specific learning disabilities, are neurodevelopmental conditions characterized by persistent difficulties in acquiring and using specific academic skills, such as reading, writing, or mathematics, in individuals with otherwise normal intellectual abilities and adequate educational opportunities. These disorders manifest despite appropriate instruction and intervention, typically becoming evident during the school years when academic demands increase. According to the DSM-5, diagnosis requires difficulties in at least one academic domain that have persisted for at least six months, not better explained by intellectual disabilities, sensory impairments, or neurological conditions.^[60]^[61] The primary subtypes include dyslexia, which involves impairments in accurate and fluent word recognition, poor decoding, and spelling abilities; dysgraphia, characterized by difficulties with written expression, including handwriting, spelling, and organizing ideas; and dyscalculia, marked by challenges in understanding numbers, performing calculations, and grasping mathematical reasoning. These subtypes are distinguished by their targeted impact on academic domains but often co-occur, with dyslexia and dyscalculia showing comorbidity rates of around 20-40% in affected children. The prevalence of specific learning disorders is notable, with dyslexia affecting approximately 5-10% of school-aged children and dyscalculia impacting 3-6%, making them among the most common neurodevelopmental conditions. Neurobiologically, these disorders are linked to atypical functioning in left-hemisphere networks, particularly the occipitotemporal and temporoparietal regions involved in phonological processing and symbolic representation, as evidenced by reduced activation in the visual word form area during reading tasks in individuals with dyslexia.^[62]^[63]^[64] Diagnosis relies on a comprehensive evaluation demonstrating a significant discrepancy between an individual's general intellectual ability and academic achievement, often quantified as performance at least 1.5 standard deviations below age-expected levels in standardized tests. For instance, the Woodcock-Johnson IV battery is commonly used to assess this gap, measuring cognitive abilities alongside achievement in reading, writing, and math to identify patterns of underachievement not attributable to external factors. Additional criteria include evidence of early onset during formal schooling and interference with academic or daily functioning, with assessments ruling out alternative explanations like inadequate education.^[65]^[66]^[67] Interventions for specific learning disorders emphasize evidence-based, targeted approaches, such as multisensory structured literacy programs for dyslexia or explicit math instruction for dyscalculia, which can substantially mitigate long-term impacts when initiated early. Screening by age 6, during the transition to formal schooling, allows for timely identification and support, with studies indicating that early intervention leads to improved developmental outcomes in over 50% of at-risk children, enhancing academic progress and reducing secondary emotional challenges.^[68]

Emerging and overlapping classifications

In the 11th revision of the International Classification of Diseases (ICD-11), implemented from 2022 onward, neurodevelopmental disorders were restructured as the first major grouping in the chapter on mental, behavioral, and neurodevelopmental disorders, encompassing conditions previously scattered across ICD-10 categories such as mental retardation and disorders of psychological development.^[69] Intellectual disabilities were specifically reclassified as "disorders of intellectual development" to emphasize developmental origins and reduce associated stigma, replacing outdated terminology like "mental retardation" with a focus on behavioral indicators and functional impairments across mild, moderate, severe, and profound levels.^[70] This shift aims to better reflect the neurobiological basis of these conditions while facilitating more precise clinical and research applications. Additionally, ICD-11 acknowledges significant overlaps with neurological conditions, including neurodevelopmental disorders comorbid with epilepsy, such as certain epileptic encephalopathies that manifest early developmental delays and cognitive impairments, though epilepsy itself remains classified under nervous system disorders.^[71] Emerging research highlights conditions that challenge traditional boundaries of neurodevelopmental disorders, such as sensory processing disorder (SPD), which involves atypical responses to sensory stimuli but remains debated for formal inclusion due to insufficient evidence of distinct neurobiological markers separate from established disorders like autism spectrum disorder (ASD).^[72] Similarly, internet gaming disorder, recognized in ICD-11 as a disorder due to addictive behaviors, has been discussed in 2024 American Psychiatric Association (APA) contexts as potentially overlapping with neurodevelopmental vulnerabilities, particularly in youth with attention-deficit/hyperactivity disorder (ADHD) or ASD, where excessive gaming may exacerbate executive function deficits.^[73] These discussions underscore the need for longitudinal studies to determine if such behavioral patterns warrant reclassification within neurodevelopmental frameworks. Overlaps between established neurodevelopmental disorders are increasingly documented, with co-occurrence rates between ASD and ADHD estimated at 50-70% in clinical populations, complicating differential diagnosis and treatment planning.^[74] Recent 2025 studies on the broad autism phenotype (BAP)—subclinical traits like social aloofness and rigid thinking in non-autistic relatives—further illuminate these intersections, revealing genetic and phenotypic heterogeneity that links BAP to increased risks for milder neurodevelopmental variations across family members.^[75] Research gaps persist, particularly in refining developmental language disorder (DLD) post-2024, where updated screening guidelines emphasize earlier identification around age 2.5 years to capture subtle grammatical and vocabulary delays not fully explained by other etiologies.^[76]

Signs and Symptoms

Core presentations

Neurodevelopmental disorders are characterized by delays or deviations in the acquisition of developmental milestones across multiple domains, including cognitive, motor, language, social, and adaptive skills. These delays often manifest as failure to achieve expected benchmarks, such as speaking first words by 12 months or forming simple sentences by age 2, and developing reciprocal social interactions by age 3.^[77]^[78] Behavioral issues are also prominent, including excessive tantrums, withdrawal from social engagement, or difficulties in self-regulation, which can interfere with daily functioning. Executive function deficits, such as difficulties with planning and impulse control, are also common across these disorders.^[79]^[80]^[81] Presentations vary by age, with infancy often showing subtle signs like poor eye contact, lack of responsive smiling, or reduced responsiveness to stimuli by 6 months. In preschool years (ages 2-5), children may exhibit repetitive or restricted play patterns, intense emotional outbursts, or challenges in group activities. By school age (6 years and older), academic struggles become evident, such as difficulties with reading, writing, or sustaining attention in classroom settings, alongside persistent social awkwardness.^[5]^[78] The severity of core presentations spans a broad spectrum, from mild forms where individuals miss subtle social cues or experience minor coordination issues, to severe cases involving nonverbal communication, profound intellectual impairment, or self-injurious behaviors that require substantial support. For instance, in autism spectrum disorder, severity levels range from requiring minimal support to full-time care, while attention-deficit/hyperactivity disorder may present as predominantly inattentive or hyperactive-impulsive. ADHD, characterized by hyperactivity and inattention, affects approximately 10% of children and often co-occurs with other neurodevelopmental disorders.^[81]^[82]^[15] Recent observational data highlight the prevalence of specific features across neurodevelopmental disorders, with sensory overload, manifesting as hypersensitivity to sounds, lights, or textures, affects 60-80% of individuals, contributing to behavioral dysregulation and withdrawal.^[83]^[84]

Associated comorbidities

Neurodevelopmental disorders frequently co-occur with mental health conditions, complicating clinical management and quality of life. Anxiety disorders affect approximately 40% of individuals with autism spectrum disorder (ASD), often manifesting as social phobia or generalized anxiety that exacerbates core social challenges.^[85] In adults with attention-deficit/hyperactivity disorder (ADHD), depression prevalence reaches about 30%, contributing to higher rates of mood dysregulation and functional impairment compared to the general population.^[86] Sleep disorders, including insomnia and circadian rhythm disruptions, are reported in 50-80% of children and adolescents across various neurodevelopmental disorders, such as ASD and ADHD, leading to daytime fatigue and worsened behavioral symptoms.^[87] Physical comorbidities are also prevalent, particularly gastrointestinal (GI) issues in ASD, where dysbiosis in the gut microbiome has been linked to chronic constipation, diarrhea, and abdominal pain in up to 70% of cases, as evidenced by 2024 studies highlighting altered microbial compositions.^[88] Epilepsy co-occurs in 20-30% of individuals with intellectual developmental disorders, with prevalence estimates averaging 22% in community samples, often requiring specialized anticonvulsant management to prevent cognitive decline.^[89] Long-term effects of these comorbidities include heightened obesity risk, particularly from side effects of medications like antipsychotics used for behavioral control in ADHD and ASD, which can promote weight gain and metabolic syndrome through appetite stimulation and sedentary lifestyles.^[90] Social isolation stemming from these conditions contributes to unemployment rates as high as 80% in severe cases of neurodevelopmental disorders, such as profound ASD or intellectual disability, limiting economic independence and social integration.^[91] Integrated care models, which combine psychiatric, medical, and behavioral interventions, have shown promise in improving symptom control and healthcare access.^[92] These comorbidities collectively contribute to reduced life expectancy, with epidemiological data indicating approximately 16-18 years shorter lifespan in ASD due to associated health risks.

Causes and Risk Factors

Genetic factors

Neurodevelopmental disorders exhibit substantial genetic contributions, with twin studies consistently demonstrating high heritability. For autism spectrum disorder (ASD), meta-analyses of twin and family studies estimate heritability at 70-80%, indicating that genetic factors account for the majority of phenotypic variance.^[93] Similarly, for attention-deficit/hyperactivity disorder (ADHD), heritability is estimated at approximately 74% based on comprehensive twin study meta-analyses.^[94] These estimates underscore the polygenic and multifactorial nature of these disorders, where both common and rare genetic variants play key roles, though shared environmental influences may modulate expression in complex ways. Specific genetic variants have been implicated in subsets of neurodevelopmental disorders. In ASD, mutations in the CHD8 gene occur in about 1% of cases and are associated with a distinct subtype characterized by macrocephaly and gastrointestinal issues.^[95] For language-related neurodevelopmental disorders, variants in the CNTNAP2 gene are linked to deficits in specific language impairment and broader communication challenges, disrupting neural connectivity in language processing regions.^[96] Copy number variations (CNVs), such as deletions or duplications, contribute to 10-20% of cases of intellectual disability, often involving multiple genes and leading to syndromic presentations with cognitive and behavioral impairments.^[97] Certain neurodevelopmental disorders arise from well-defined monogenic causes, providing clear syndromic examples. Rett syndrome, a severe disorder involving regression of developmental milestones, results primarily from mutations in the MECP2 gene on the X chromosome, affecting over 95% of classic cases and leading to intellectual disability, seizures, and motor dysfunction.^[98] Tuberous sclerosis complex, another syndromic condition, stems from mutations in the TSC1 or TSC2 genes, which regulate cell growth via the mTOR pathway, resulting in tubers, epilepsy, and high rates of autism and intellectual disability in affected individuals.^[99] Advancements in genomics have introduced polygenic risk scores (PRS) as tools for assessing susceptibility to neurodevelopmental disorders. Emerging 2025 models integrating large-scale genome-wide association studies achieve prediction accuracies of approximately 2-5% explained variance for ASD liability, with up to 11% for related traits like age at diagnosis, capturing the cumulative effect of thousands of common variants and aiding in risk stratification, though clinical utility remains limited by environmental interactions.^[100]^[101]

Environmental and prenatal influences

Prenatal environmental exposures play a significant role in the etiology of neurodevelopmental disorders. Maternal smoking during pregnancy has been consistently linked to an increased risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, with pooled analyses indicating more than a two-fold elevation in odds (odds ratio >2). This association persists after controlling for confounding factors such as socioeconomic status and maternal mental health. Similarly, prenatal alcohol exposure can result in fetal alcohol spectrum disorders (FASD), a range of neurodevelopmental conditions characterized by cognitive, behavioral, and social impairments; prevalence estimates indicate that up to 5% of school-aged children in the United States may be affected.^[102]^[103] Nutritional deficiencies during pregnancy also contribute to neurodevelopmental risks. Severe iodine deficiency in utero leads to endemic cretinism, a form of intellectual impairment marked by profound mental retardation, neurological deficits, and sometimes deaf-mutism, representing one of the most preventable causes of cognitive disability worldwide. Conversely, preconceptional and periconceptional folate supplementation has demonstrated substantial protective effects; high-dose folic acid (4 mg daily) reduces the risk of recurrent neural tube defects—congenital anomalies like spina bifida that can cause neurodevelopmental impairments—by more than 70%, with evidence from recent reviews affirming this impact through 2024.^[104]^[105] Postnatal social deprivation, particularly prolonged institutionalization, exacerbates vulnerability to neurodevelopmental symptoms. Studies of Romanian orphans adopted into families after early institutional care reveal that such deprivation is associated with substantially elevated autism-like symptoms, including social withdrawal and repetitive behaviors, with rates of quasi-autistic traits reaching up to 12-25% in affected cohorts—far exceeding general population prevalence—and persisting into adulthood in 30% or more experiencing multiple developmental problems. This heightened risk stems from disrupted attachment and sensory stimulation during critical periods.^[106]^[107] Childhood trauma, including abuse, further elevates the likelihood of neurodevelopmental disorders through mechanisms involving stress hormone dysregulation, such as altered hypothalamic-pituitary-adrenal axis function. Exposure to moderate-to-severe abuse or neglect increases the odds of ADHD diagnosis by approximately two-fold (odds ratio ≈2.0), with similar patterns observed for other conditions like attachment disorders; this effect is mediated by chronic elevations in cortisol, impairing brain regions involved in executive function and emotion regulation.^[108]

Infectious and metabolic contributors

Infections during pregnancy represent a significant contributor to neurodevelopmental disorders (NDDs), primarily through direct viral invasion of the fetal central nervous system or secondary inflammatory responses that disrupt brain development. Congenital rubella syndrome (CRS), resulting from maternal rubella virus infection, leads to microcephaly, sensorineural hearing loss, and intellectual disability in affected infants. According to World Health Organization estimates, approximately 100,000 infants are born with CRS annually worldwide, predominantly in regions with low vaccination coverage. Similarly, Zika virus infection during pregnancy causes congenital Zika syndrome (CZS), characterized by microcephaly and long-term neurodevelopmental delays, with 5-14% of exposed fetuses developing severe manifestations. Recent Zika outbreaks in 2024, including resurgences in the Americas and Asia, have been associated with elevated incidences of microcephaly and related NDDs, underscoring the virus's ongoing public health impact. Maternal influenza infection has also been linked to increased autism spectrum disorder (ASD) risk in offspring, with meta-analyses indicating a 1.3-fold elevated odds for ASD following prenatal fever or infection. Immune dysfunction further implicates autoimmune processes in NDD etiology, where aberrant maternal or postnatal immune responses target neural tissues. Autoimmune encephalitis, involving autoantibodies against neuronal surface proteins, can present with neurodevelopmental regression, seizures, and behavioral changes mimicking ASD or other NDDs, particularly in pediatric cases. Maternal autoantibodies reactive to fetal brain proteins, such as those targeting folate receptor alpha or other neuronal antigens, have been identified in 18-26% of mothers of children with ASD, potentially contributing to 5-10% of idiopathic NDD cases through disrupted early brain signaling and gene expression. Recent 2025 studies have demonstrated that gestational exposure to these maternal autoantibodies alters fetal brain development, increasing vulnerability to ASD and related disorders via immune-mediated inflammation.^[109] Metabolic disorders disrupt energy production and neurotransmitter balance, leading to NDDs when untreated. Phenylketonuria (PKU), an inborn error of phenylalanine metabolism, results in severe intellectual disability if not managed, with untreated individuals exhibiting average IQ scores below 50 due to toxic accumulation of phenylalanine damaging the developing brain. Mitochondrial disorders, which impair cellular energy generation, account for 1-2% of cases involving developmental delays, often presenting with hypotonia, seizures, and cognitive impairment across NDD spectra like ASD. Early interventions, such as newborn screening for metabolic conditions including PKU and certain mitochondrial-related disorders, enable timely dietary or supportive therapies that prevent up to 90% of severe neurodevelopmental outcomes by averting metabolic crises and preserving cognitive function.

Diagnosis

Diagnostic criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), published in 2013 by the American Psychiatric Association, classifies neurodevelopmental disorders as a broad category of conditions with onset during the developmental period, marked by deficits in the acquisition, retention, or application of cognitive, motor, language, or social functions that result in significant impairments in personal, social, academic, or occupational functioning. Core diagnostic criteria across specific disorders within this category require evidence of clinically significant impairment persisting across multiple contexts, with onset typically before school entry, and symptoms not better accounted for by intellectual developmental disorder, global developmental delay, or environmental deprivation.^[9] The 2022 text revision (DSM-5-TR) maintains these criteria while updating descriptive text, coding alignments with ICD-10, and cultural considerations to enhance clinical utility without altering the foundational requirements.^[110] The International Classification of Diseases, 11th Revision (ICD-11), effective globally from 2022 and developed by the World Health Organization, adopts a lifespan developmental framework for neurodevelopmental disorders, consolidating them into a unified chapter that encompasses intellectual, communication, motor, and other developmental deviations, allowing for specifiers denoting severity (mild, moderate, severe, profound) and co-occurring conditions to reflect clinical complexity.^[25] Diagnostic requirements emphasize persistent difficulties in acquiring and executing domain-specific functions attributable to atypical brain development, with exclusions for cases primarily due to sensory impairments, neurological conditions, or adverse environments, promoting harmonization with DSM-5 while prioritizing global applicability.^[111] This grouping acknowledges the high degree of overlap and comorbidity among these disorders, reducing traditional diagnostic silos through flexible qualifiers that capture multifaceted presentations.^[112] Both classification systems underscore key principles such as early identification to facilitate timely intervention, exemplified by routine screening for autism spectrum disorder around age 2 using parent-report tools like the Modified Checklist for Autism in Toddlers (M-CHAT), which assesses risk through 23 behavioral items and has demonstrated sensitivity in detecting early signs.^[113] Additionally, cultural adaptations are integral, with DSM-5 incorporating a Cultural Formulation Interview to contextualize symptoms within cultural norms and ICD-11 providing guidelines for culturally informed assessments to mitigate bias in diverse populations.^[114]

Assessment and screening methods

Assessment and screening for neurodevelopmental disorders typically begin with standardized tools to identify potential delays or atypical development in young children, followed by more in-depth evaluations when indicated. Universal screening is recommended by the American Academy of Pediatrics (AAP) at well-child visits, including general developmental checks at 9, 18, and 30 months, and autism-specific screening at 18 and 24 months, to facilitate early detection and intervention.^[115]^[113] Common screening instruments include the Ages & Stages Questionnaires (ASQ-3), a parent-completed tool that assesses communication, gross motor, fine motor, problem-solving, and personal-social skills in children from 1 to 66 months, demonstrating high sensitivity and specificity for identifying developmental delays.^[116] For autism spectrum disorder (ASD), the Social Communication Questionnaire (SCQ) serves as a brief parent-report measure evaluating social interaction, communication, and repetitive behaviors, with established validity for flagging children needing further assessment.^[117] Comprehensive assessments involve multidisciplinary teams, including psychologists, neurologists, and speech-language pathologists, to confirm diagnoses using gold-standard tools such as the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2), which observes social communication and play in a semi-structured format across ages and developmental levels.^[118] For attention-deficit/hyperactivity disorder (ADHD), the Conners scales, including parent and teacher rating forms, quantify inattention, hyperactivity, and impulsivity symptoms, aiding in differential diagnosis.^[119] In complex cases with suspected structural anomalies, such as regression or seizures, magnetic resonance imaging (MRI) is employed to rule out organic causes, though routine use is not recommended due to low yield in uncomplicated presentations.^[120] Challenges in assessment include risks of overdiagnosis, particularly for ADHD, where systematic reviews indicate substantial evidence of overdiagnosis, including false positives in community samples due to overlapping symptoms with typical behaviors or other conditions.^[121] Post-2024 expansions in telehealth, with flexibilities extended through December 2025, have addressed access barriers, particularly in rural areas, with studies indicating improvements in timely evaluations for ASD through remote administration of screening and diagnostic tools.^[122]^[123] Outcome measures for tracking progress focus on adaptive functioning, with the Vineland Adaptive Behavior Scales (Vineland-3) providing a comprehensive, informant-based evaluation of daily living skills, socialization, and communication, enabling longitudinal monitoring of intervention efficacy in neurodevelopmental disorders.^[124]

Management and Treatment

Behavioral and educational interventions

Behavioral and educational interventions form a cornerstone of management for neurodevelopmental disorders, emphasizing skill development, behavior modification, and tailored learning support to enhance daily functioning and academic progress. These approaches are particularly effective when initiated early, targeting core symptoms such as social deficits, inattention, and repetitive behaviors across conditions like autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD).^[125] Applied behavior analysis (ABA) is a widely used evidence-based therapy for children with ASD, involving systematic reinforcement of desired behaviors to reduce maladaptive ones. Intensive ABA programs, typically delivered 20-40 hours per week, have been shown in meta-analyses to significantly improve communication, adaptive skills, and cognitive outcomes, with effect sizes indicating moderate to large benefits.^[126]^[127] Early intensive behavioral intervention (EIBI), a form of ABA starting at ages 2-3, focuses on comprehensive skill-building in natural environments and has demonstrated sustained gains in intellectual functioning and adaptive behavior when provided at high intensity.^[125]^[128] In educational settings, Individualized Education Programs (IEPs) under the U.S. Individuals with Disabilities Education Act (IDEA) provide legally mandated, customized plans to support students with neurodevelopmental disorders, including goals for academic, social, and functional skills. These programs ensure access to free appropriate public education through specialized instruction and related services, often incorporating ABA principles. School accommodations, such as extended time on tests and sensory breaks, further facilitate participation and reduce barriers for students with ADHD or ASD. Cognitive-behavioral therapy (CBT) adapted for ADHD addresses comorbid anxiety by teaching coping strategies, emotional regulation, and problem-solving skills, leading to significant symptom reduction in approximately 60% of cases based on psychotherapy outcome data.^[129] Meta-analyses confirm CBT's efficacy in alleviating anxiety and improving overall functioning in adults and adolescents with ADHD, particularly when targeting emotional dysregulation.^[130] Inclusive education models, which integrate students with neurodevelopmental disorders into general classrooms with supports, have been linked to enhanced social and academic outcomes, including improved peer interactions and self-esteem, as evidenced by recent reviews.^[131] These interventions prioritize environmental modifications over segregation, yielding better long-term adaptive skills compared to isolated special education settings.^[132]

Pharmacological and medical approaches

Pharmacological interventions for neurodevelopmental disorders primarily target symptom management rather than addressing underlying causes, with treatments tailored to specific conditions like attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). For ADHD, stimulant medications such as methylphenidate (commonly known as Ritalin) are first-line options, demonstrating efficacy in reducing core symptoms of inattention, hyperactivity, and impulsivity in approximately 70-80% of children and adolescents based on response rates from randomized controlled trials.^[133] Non-stimulant alternatives like atomoxetine, a selective norepinephrine reuptake inhibitor, are used when stimulants are contraindicated or ineffective, showing response rates around 50% in improving ADHD symptoms over 12 weeks in comparative studies.^[134] In ASD, atypical antipsychotics like risperidone are FDA-approved for managing severe irritability, including aggression and self-injurious behaviors, with approval granted in 2006 for children and adolescents aged 5-16 years following pivotal trials demonstrating significant symptom reduction.^[135] Clinical data indicate that risperidone reduces irritability scores by 50-60% compared to placebo, as measured by standardized scales like the Aberrant Behavior Checklist, with effects most pronounced in short-term use.^[136] Common side effects of these medications require careful monitoring to mitigate risks. Stimulants like methylphenidate can lead to appetite suppression and temporary growth suppression in 10-20% of pediatric patients, potentially resulting in modest height reductions of 1-2 cm over the first few years of treatment, though long-term impacts on final adult height are minimal.^[137] For cardiac risks, 2024 clinical guidelines from organizations like Community Behavioral Health recommend routine monitoring of heart rate and blood pressure at every visit for patients on stimulants or non-stimulants, particularly those with pre-existing cardiovascular conditions, to detect elevations early and adjust dosing as needed.^[138]

Supportive and family-based strategies

Supportive and family-based strategies play a crucial role in addressing the holistic needs of individuals with neurodevelopmental disorders (NDDs) and their families, emphasizing emotional, social, and practical support to enhance quality of life and resilience. These approaches focus on strengthening family dynamics, reducing caregiver stress, and facilitating access to community resources, often integrated with broader care plans to promote long-term independence. Family therapy, particularly parent training programs such as Parent-Child Interaction Therapy (PCIT), has demonstrated effectiveness in improving parent-child interactions and alleviating caregiver stress for families affected by NDDs. PCIT involves live coaching for parents to enhance positive communication and discipline skills, leading to significant reductions in parenting stress and child disruptive behaviors in populations including those with autism spectrum disorder (ASD) and developmental delays. For instance, studies show that PCIT can reduce reported parenting stress by up to 40% in families of children with behavioral challenges associated with NDDs, as evidenced in 2024 randomized trials evaluating its impact on emotion regulation and family functioning.^[139]^[140] Caregivers of individuals with NDDs face substantial emotional and physical demands, with burnout rates estimated at 30-50% due to chronic stress, sleep disruptions, and limited personal time, particularly among parents of children with ASD or intellectual disabilities. Support groups and peer-led interventions mitigate this burden by fostering resilience through shared experiences, coping strategies, and emotional validation, with participation linked to improved mental health outcomes and reduced isolation for caregivers. Research indicates that group-based support can enhance family resilience by 25-35% in self-reported measures, helping caregivers build adaptive skills and access tailored resources.^[141]^[142]^[143] Community services provide essential relief and skill-building opportunities, including respite care and vocational training programs designed to support families and promote independence for individuals with NDDs. Respite care offers temporary, supervised relief for caregivers, allowing short-term breaks while ensuring safe, structured activities that can improve social skills in children with ASD or other NDDs, with programs often available through state agencies at no or low cost. Vocational training initiatives, such as those offered by disability service centers, focus on job readiness through counseling, skill assessments, and workplace placements, enabling adults with NDDs to achieve competitive employment and financial autonomy. Transition planning to adulthood, guided by frameworks like those from the World Health Organization's 2025 mental health policy updates emphasizing rights-based community inclusion and coordinated services, starts as early as age 14 to address gaps in adult support systems.^[144]^[145]^[146]^[147] Advocacy efforts by organizations such as Autism Speaks amplify these strategies by raising awareness, funding research, and lobbying for policy changes that benefit families of individuals with NDDs. Autism Speaks provides resources like toolkits for family support, community events, and advocacy training to promote inclusion across the lifespan, influencing legislation for better access to therapies and services. In the United States, policies like Achieving a Better Life Experience (ABLE) accounts offer tax-advantaged savings vehicles for qualified disability expenses, such as housing, transportation, and education, allowing families to save up to $19,000 annually without affecting eligibility for public benefits, thereby easing financial burdens for those with NDDs. These advocacy-driven policies complement educational plans like Individualized Education Programs (IEPs) by addressing long-term financial and social needs.^[148]^[149]^[150]

Research Directions

Current studies and advances

Recent neuroimaging studies utilizing functional magnetic resonance imaging (fMRI) have illuminated altered brain connectivity patterns in attention-deficit/hyperactivity disorder (ADHD). A 2024 study from the National Institutes of Health revealed elevated brain activity connecting the frontal cortex with deeper information-processing centers in youth with ADHD, suggesting hyperconnectivity that may underlie attentional deficits.^[151] Similarly, analyses of resting-state fMRI data in 2024 identified abnormal functional connectivity primarily in frontal, temporal, parietal, and cerebellar regions among individuals with ADHD, highlighting these areas as key sites of dysfunction.^[152] In parallel, artificial intelligence (AI)-driven electroencephalography (EEG) approaches have advanced early detection of autism spectrum disorder (ASD). A 2025 review of machine learning classifiers applied to EEG-derived features, such as neural oscillatory patterns and connectivity measures, reported diagnostic accuracies ranging from 85% to 99% for identifying ASD in young children.^[153] Genetic research into neurodevelopmental disorders continues to progress with innovations in gene editing and risk prediction. Preclinical investigations into gene therapy for fragile X syndrome, a leading monogenic cause of intellectual disability and ASD, are exploring targeted corrections to the FMR1 gene mutation, with preliminary perspectives indicating potential for human trials in related genetic neurodevelopmental conditions.^[154] Concurrently, advancements in polygenic risk scoring have improved predictive capabilities; a 2025 study enhanced polygenic scores for ADHD, demonstrating their utility in associating common variants with disorder risk and explaining modest portions of phenotypic variance.^[155] A 2024 analysis further showed that polygenic scores for neurodevelopmental conditions correlate with rare variant risk components, aiding in dissecting shared genetic architectures across disorders.^[156] Epidemiological efforts, such as the Adolescent Brain Cognitive Development (ABCD) study initiated in 2015, provide longitudinal insights into environmental influences on neurodevelopment. This ongoing cohort tracks over 11,000 children aged 9-10 at baseline through adolescence, examining how factors like prenatal exposures, neighborhood environments, and psychosocial stressors impact brain structure, cognition, and mental health outcomes in neurodevelopmental disorders. Recent ABCD-derived publications in 2024 have linked multi-system environmental adversities to subcortical volume changes and cognitive trajectories, underscoring gene-environment interactions in disorder etiology.^[157] Research on comorbidities within neurodevelopmental disorders increasingly focuses on the gut-brain axis, particularly in ASD. A 2025 study correlated altered gut microbiota composition with behavioral problems in individuals with autism, implicating microbial dysbiosis in symptom severity via tryptophan-related pathways.^[158] Functional gastrointestinal disorders, prevalent in up to 50% or more of ASD cases, further link gut-brain axis disruptions to heightened anxiety, irritability, and social withdrawal, as evidenced in 2025 analyses of comorbid profiles.^[159] These findings highlight the axis as a bidirectional mediator in comorbidity mechanisms.^[160]

Future therapeutic developments

Emerging gene therapies, particularly antisense oligonucleotides (ASOs), hold significant promise for treating specific neurodevelopmental disorders such as Angelman syndrome. GTX-102, developed by Ultragenyx, is an investigational ASO that targets the UBE3A-ATS transcript to reactivate the silenced paternal UBE3A gene. In phase 1/2 trials involving pediatric patients, GTX-102 demonstrated rapid and clinically meaningful improvements across cognitive, communication, and behavioral domains, with 97% of participants in medium- and high-dose groups showing overall symptom improvements after six months of treatment.^[161] The phase 3 Aspire study, evaluating GTX-102 in deletion-type Angelman syndrome, completed enrollment in July 2025, with topline results anticipated in 2026.^[162] Similarly, Ionis Pharmaceuticals' ION582, another ASO targeting UBE3A-ATS, advanced to phase 3 planning in 2025 based on positive phase 1/2 data showing enhancements in motor function and adaptive behavior.^[163] These developments build on ongoing genetic studies identifying UBE3A-related mechanisms in neurodevelopment. Stem cell interventions, including neural progenitor cell transplants, are advancing toward clinical application for motor-related neurodevelopmental disorders like cerebral palsy. Preclinical studies in 2025 using rat models of cerebral palsy demonstrated that neural progenitor cell transplantation promotes structural recovery in the brain and improves motor function through neurogenesis and reduced inflammation.^[164] Human trials, such as phase 1/2 studies evaluating stem cell administration, have confirmed safety and preliminary efficacy in enhancing motor skills and adaptive behaviors in children with cerebral palsy, with no severe adverse events reported.^[165] A 2025 meta-analysis of randomized controlled trials further supports stem cell therapy's potential, showing moderate improvements in gross motor function scores (SMD 0.50) and overall safety profile across 13 studies.^[166] Planned phase 2/3 trials extending into 2026 aim to optimize dosing and delivery methods, such as intrathecal injection, to broaden applicability. Digital therapeutics are emerging as scalable tools for addressing social and cognitive challenges in neurodevelopmental disorders, particularly autism spectrum disorder (ASD). Virtual reality (VR)-based social skills training programs immerse users in simulated environments to practice interactions, with pilot studies reporting high engagement levels, including completion rates of 87.9% and minimal side effects like mild dizziness.^[167] A 2025 systematic review of VR interventions in children and adolescents with ASD found consistent positive effects on social responsiveness, with effect sizes ranging from moderate to large on standardized measures like the Social Responsiveness Scale.^[168] Complementing VR, artificial intelligence (AI)-driven platforms enable personalized treatment plans by analyzing developmental profiles and real-time responses to tailor interventions, such as adaptive cognitive training apps that adjust difficulty based on user performance. For instance, the FDA-authorized Cognoa system uses AI to support early ASD diagnosis. AI platforms in general have demonstrated improved adaptive functioning in pilot implementations.^[169]^[170] Preventive strategies leveraging prenatal screening for copy number variations (CNVs) offer opportunities to mitigate neurodevelopmental disorder risks through timely interventions. Non-invasive prenatal testing (NIPT) detects pathogenic CNVs associated with conditions like 22q11.2 deletion syndrome, enabling early postnatal monitoring and therapies that can lessen symptom severity.^[171] Clinical studies indicate that identifying CNVs prenatally facilitates personalized early intervention plans, such as targeted speech or motor therapies. Ongoing advancements in CNV-seq technology enhance detection accuracy for clinically significant variants, potentially reducing the long-term incidence of severe manifestations through proactive family support and genetic counseling.^[172] Recent 2025 findings from the ENIGMA consortium have further elucidated brain structural variations in neurodevelopmental disorders, informing future preventive approaches.^[173]

References

[1]
Mental disorders - World Health Organization (WHO)
Sep 30, 2025 · Neurodevelopmental disorders are behavioural and cognitive disorders, that arise during the developmental period, and involve significant ...
[2]
Neurodevelopmental disorders—the history and future of a ... - NIH
In DSM‑5 , NDDs are defined as a group of conditions with onset in the developmental period, inducing deficits that produce impairments of functioning. NDDs ...
[3]
Neurodevelopmental Disorders: Past, Present, and Future - PMC
Dec 24, 2022 · Neurodevelopmental disorders currently include intellectual disabilities, communication disorders, autism spectrum disorder (ASD), ADHD, ...
[4]
Neurodevelopmental Disorders (NDDs): Beyond the Clinical ... - NIH
Jan 3, 2023 · Neurodevelopmental disorders (NDDs) are complex and heterogeneous disorders that affect the growth and development of the brain and are ...
[5]
Developmental Disability Basics | Child Development - CDC
Jun 2, 2025 · Developmental disabilities are a group of conditions due to an impairment in physical, learning, language, or behavior areas.
[6]
Neurodevelopmental Disorders - Psychiatry Online
Mar 18, 2022 · The neurodevelopmental disorders are a group of conditions with onset in the developmental period. The disorders typically manifest early in ...
[7]
Neurodevelopmental Disorders - Psychiatry.org
Neurodevelopmental disorders refers to a group of disorders that begin in childhood. They affect the development and function of the brain.
[8]
From Neurodevelopmental to Neurodegenerative Disorders
CNS disorders are dichotomized as early onset neurodevelopmental disorders and late-onset neurodegenerative diseases (Taoufik et al., 2018). Neurodegenerative ...
[9]
Disability - World Health Organization (WHO)
Mar 7, 2023 · An estimated 1.3 billion people experience significant disability. This represents 16% of the world's population, or 1 in 6 of us.World report on · 10 Facts on disability · WHO Policy on disability
[10]
Autism - World Health Organization (WHO)
Sep 17, 2025 · It is estimated that worldwide in 2021 about 1 in 127 persons had autism (1). This estimate represents an average figure, and reported ...
[11]
Prevalence and Early Identification of Autism Spectrum ... - CDC
Apr 17, 2025 · Results: Among children aged 8 years in 2022, ASD prevalence was 32.2 per 1,000 children (one in 31) across the 16 sites, ranging from 9.7 in ...Asd Prevalence Among... · Early Asd Identification... · Asd Testing Among Children...
[12]
Data and Statistics on ADHD - CDC
May 22, 2024 · An estimated 7 million (11.4%) US children aged 3–17 years have ever been diagnosed with ADHD, according to a national survey of parents using data from 2022.
[13]
Prevalence of intellectual disability among adults born in the 1980s ...
Jan 17, 2024 · Overall, we estimate that 818 564 adults with ID who were approximately 21-41 years were living in the United States as of 2021.
[14]
Towards understanding sex differences in autism spectrum disorders
Jun 15, 2024 · 2. Sex differences in ASD. Historically, males have been diagnosed with ASD more frequently than females, with a ratio of about 4:1 ( ...
[15]
Urban–Rural Disparity in the Incidence of Diagnosed Autism ...
Feb 7, 2022 · Autism spectrum disorder (ASD) is reportedly more prevalent in urban areas partly because of better accessibility and affordability to healthcare.
[16]
Risk of neuropsychiatric and related conditions associated ... - Nature
Jul 24, 2025 · The COVID-19 pandemic has been associated with increased neuropsychiatric conditions in children and youths, with evidence suggesting that ...
[17]
Poverty and low socioeconomic status affect cognitive development ...
Apr 15, 2024 · A new review in De Gruyter's Reviews in the Neurosciences suggests that poverty and low socioeconomic status (SES) are key contributory factors.
[18]
Epidemiological trends in autism and other neurodevelopmental ...
Jun 2, 2025 · Low-income countries report the lowest rates, often below 0.2%, due to underdiagnosis, limited access to services, and lack of culturally ...
[19]
Facts About ADHD Throughout the Years - CDC
Oct 23, 2024 · There has been an upward trend in national estimates of parent-reported ADHD diagnoses across different surveys, using different age ranges.
[20]
Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity ...
Aug 31, 2018 · The estimated prevalence of diagnosed ADHD increased from 6.1% in 1997-1998 to 10.2% in 2015-2016 (P for trend <. 001) (Figure).
[21]
The changing prevalence of ADHD? A systematic review
ADHD prevalence estimates vary in children by age group; a review of pre-2020 studies reported a prevalence rate of 7.6 % in children aged 3–11 and 5.6 % in ...
[22]
Clinical descriptions and diagnostic requirements for ICD-11 mental ...
Mar 8, 2024 · Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (CDDR). 8 March 2024.
[23]
Defining Criteria for Intellectual Disability - AAIDD
Generally, an IQ test score of around 70 or as high as 75 indicates a significant limitation in intellectual functioning. Adaptive Behavior. Adaptive behavior ...
[24]
Prevalence of intellectual disability: A meta-analysis of population ...
▷ The prevalence of intellectual disability across the world is around 1%. ▷ The prevalence is almost two times more in low and middle income countries ...
[25]
Data and Statistics on Fragile X Syndrome - CDC
May 16, 2024 · Fragile X syndrome (FXS) is the most common known cause of inherited intellectual disability. · FXS affects both males and females, although ...
[26]
Clinical Characteristics of Intellectual Disabilities - NCBI - NIH
The DSM-5 diagnosis of ID requires the satisfaction of three criteria: 1. Deficits in intellectual functioning—“reasoning, problem solving, planning, abstract ...DIAGNOSIS AND ASSESSMENT · DEMOGRAPHIC FACTORS... · COMORBIDITIES
[27]
Neurodevelopmental Disorders - Communication Disorders
Communication disorders on this page include Stuttering, social communication disorder, Speech sound disorder, Language disorder.Missing: subtypes | Show results with:subtypes<|control11|><|separator|>
[28]
DSM-5 Child Mental Disorder Classification - NCBI - NIH
ADHD is a chronic neurodevelopmental disorder according to DSM-5 that is characterized by a persistent and pervasive pattern of inattention and/or ...Table 7, DSM-IV to DSM-5... · Table 5, DSM-IV Pervasive... · Major Depressive<|separator|>
[29]
Communication Disorders - PsychDB
Jan 15, 2021 · There are five communication disorders in the DSM-5: Language Disorder, Speech Sound Disorder (previously Phonological Disorder), Childhood ...Missing: subtypes | Show results with:subtypes
[30]
The DSM-5 introduction of the Social (Pragmatic) Communication ...
The latest edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) included the Social (Pragmatic) Communication Disorder (SPCD) as a new ...
[31]
The impact of nonverbal ability on prevalence and clinical ...
May 16, 2016 · The most commonly cited prevalence estimate of 7.4% (Tomblin et al., 1997) required an overall language deficit of −1.12SD in the context of ...Introduction · Methods · Results · Discussion
[32]
Prevalence and functional impact of social (pragmatic ... - NIH
In total, teachers reported that 8% of the mainstream school population at Year 1 scored below the 10th percentile on the social‐pragmatic composite, similar to ...
[33]
Language Disorder - PsychDB
Mar 29, 2021 · Language disorder occurs early in the developmental period. However, there is great variation in early vocabulary acquisition between ...
[34]
The Longitudinal Effects of Early Language Intervention on ... - NIH
Researchers examined whether a parent-implemented language intervention improved problem behaviors one year after intervention.
[35]
https://pmc.ncbi.nlm.nih.gov/articles/PMC10087005/
[36]
IACC Subcommittee Diagnostic Criteria - DSM-5 Planning Group
DSM-5 Diagnostic Criteria. Autism Spectrum Disorder; Social (Pragmatic) Communication Disorder; Table 2: Severity Levels for Autism Spectrum Disorder. Autism ...Missing: subtypes | Show results with:subtypes
[37]
Autism Spectrum Disorder Versus Autism Spectrum Disorders - NIH
DSM-5 introduced three major changes: 1. It merged all of the diagnoses that were under the pervasive developmental disorders category into a single disorder ...
[38]
Data and Statistics on Autism Spectrum Disorder - CDC
May 27, 2025 · These included ASD, attention-deficit/hyperactivity disorder (ADHD), blindness, and cerebral palsy, among others. ... Autism Spectrum Disorder ( ...MMWR · Prevalence Studies Data Table · Autism Data Visualization Tool
[39]
Neurobiology of sensory processing in autism spectrum disorder
Literature showed that over 96% of children with ASD report hyper and hypo-sensitivities in multiple domains, including the vestibular, somatosensory, visual, ...
[40]
Relationships between Sensory Processing and Executive ... - NIH
Jun 2, 2024 · Apart from sensitivity sensation, the ASD+ADHD group reported significantly more atypical SP than the ASD group across the other three sections.
[41]
Targeting Shank3 deficiency and paresthesia in autism spectrum ...
Mutations in SHANK3 are estimated to occur in 1–2% of people with autism and intellectual disabilities, while mutations in SHANK1 and SHANK2 are less common ( ...Introduction · Shank3 and ASD · Comorbidity of Shank3... · Treatment of ASD and...
[42]
Update on diagnostic classification in autism - PMC - NIH
Three additional and very significant changes to the ASD criteria in DSM-5 address concerns about diagnostic conversion and diagnostic independence. First is ...
[43]
What is ADHD? - Psychiatry.org
Symptoms of ADHD include inattention (not being able to keep focus), hyperactivity (excess movement that is not fitting to the setting) and impulsivity.ADHD in Adults · What Is Autism Spectrum · Disruptive, Impulse-Control...
[44]
Table 7, DSM-IV to DSM-5 Attention-Deficit/Hyperactivity Disorder ...
A. A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development, as characterized by (1) and/or (2):. 1.
[45]
Attention-deficit/hyperactivity disorder: diagnostic criteria ...
While the norm has been 6 (or more) symptoms in younger adolescents and children, at least 5 symptoms in either domain must be present to make the diagnosis in ...
[46]
The global prevalence of ADHD in children and adolescents
Apr 20, 2023 · According to the findings, the incidence of ADHD is 7.6% in children aged 3 to 12 years and 5.6% in teenagers aged 12 to 18. The findings of ...
[47]
The global prevalence of attention deficit hyperactivity disorder in ...
Oct 15, 2023 · A random effect meta-analysis of these studies showed that the global prevalence of ADHD in children and adolescents was 8.0 % (95%CI 6.0-10 %).
[48]
An overview on neurobiology and therapeutics of attention-deficit ...
The physiological changes induced by the binding of dopamine and norepinephrine to their respective receptors involve the modulation of several cognitive and ...
[49]
Attention-deficit/hyperactivity disorder | Nature Reviews Disease ...
Feb 22, 2024 · The dopaminergic system plays an important part in the regulation of movement, mood regulation, attention, learning and memory, novelty and ...
[50]
[PDF] NICHQ Vanderbilt Assessment Scale—PARENT Informant
On both the parent and teacher initial scales, the symptom assess- ment screens for symptoms that meet criteria for both inattentive. (items 1–9) and ...
[51]
NICHQ Vanderbilt Assessment Scales
Sep 12, 2002 · The NICHQ Vanderbilt Assessment Scales are used by health care professionals to help diagnose ADHD in children between the ages of 6- and 12-years.<|control11|><|separator|>
[52]
Neurodevelopmental Disorders - Motor Disorders - Psychiatry.org
Motor disorders on this page include. Tic disorders; Developmental coordination disorder; Stereotypic movement disorder ...
[53]
Developmental Coordination Disorder (Dyspraxia) - StatPearls - NCBI
Feb 24, 2024 · Developmental coordination disorder (DCD), or dyspraxia, is a neurodevelopmental disorder characterized by poor motor coordination and difficulty learning ...
[54]
Children with developmental coordination disorders: a review of ...
May 23, 2024 · The prevalence of DCD in children ranges from approximately 2 to 20%, with widely accepted international figures currently standing at 5–6% (4).
[55]
Data and Statistics on Tourette Syndrome - CDC
Jul 24, 2025 · Studies estimate that 1 out of 162 children have TS. Many children diagnosed with TS also have been diagnosed with other mental, behavioral, or ...
[56]
International Classification of Diseases (ICD)
ICD serves a broad range of uses globally and provides critical knowledge on the extent, causes and consequences of human disease and death worldwide.ICD-11 2024 release · List of Official ICD-10 updates · ICD-11 Fact Sheet · ICD-O-3Missing: neurodevelopmental | Show results with:neurodevelopmental
[57]
Developmental Coordination Disorder and Most Prevalent ... - NIH
Jul 21, 2022 · Attention Deficit/Hyperactivity Disorder (ADHD) is one of the main developmental disorders whose prevalence is estimated to be around 4–9% of ...
[58]
What Are Specific Learning Disorders? - Psychiatry.org
An estimated 5 to 15% of school-age children struggle with a learning disability. 1 An estimated 80% of those with learning disorders have an impairment in ...Search · On This Page · Diagnosis
[59]
Clinical Characteristics of Learning Disabilities - NCBI - NIH
According to DSM-5, the diagnosis of a specific learning disorder includes the following symptoms: 1. Persistent difficulties in reading, writing ...DIAGNOSIS AND ASSESSMENT · DEMOGRAPHIC FACTORS... · COMORBIDITIES
[60]
Specific Learning Disorder - PsychDB
Mar 29, 2021 · Criterion A. Difficulties learning and using academic skills, as indicated by the presence of at least one of the following symptoms that have ...Primer · DSM-5 Diagnostic Criteria
[61]
DSM-5 Changes in Diagnostic Criteria for Specific Learning ...
Criterion C refers to age at onset of problems (during the school-age years, although may not fully manifest until young adulthood in some individuals), and ...<|control11|><|separator|>
[62]
Dyscalculia and dyslexia in school-aged children - Frontiers
Jan 23, 2025 · The comorbidity of dyscalculia and dyslexia represents a significant challenge in education, affecting a considerable number of school-aged children globally.Abstract · Introduction · Current understanding of... · The future of dyscalculia and...
[63]
The New Diagnostic and Statistical Manual of Mental Disorders ...
The DSM-5 makes it clear that SLD must be specific to academic skill in the areas of reading, writing, or mathematics. No longer can clinicians diagnose ...
[64]
Use of the Woodcock-Johnson IV in the diagnosis of specific ...
The Woodcock-Johnson IV,comprising assessments of cognitive abilities, academic achievement, and oral language skills, is ideal for assessing learning ...
[65]
Differences in specific learning disability identification with ... - PubMed
This study examined identification of a specific learning disability using the Ability Achievement Discrepancy model with the Woodcock-Johnson IV (WJ-IV).
[66]
Effectiveness of early intervention and prediction of outcomes in ...
May 31, 2025 · This study underscores the effectiveness of early intervention services in Taiwan. Consistent reassessments may facilitate subsequent educational interventions.
[67]
Innovations and changes in the ICD‐11 classification of mental ...
Neurodevelopmental disorders are those that involve significant difficulties in the acquisition and execution of specific intellectual, motor, language or ...<|separator|>
[68]
Highlights of ICD-11 Classification of Mental, Behavioral, and ...
... disorders of intellectual development, an applauding effort to decrease the stigma associated. This provides a comprehensive set of behavioral indicators, ...
[69]
Overlap Between Epilepsy and Neurodevelopmental Disorders - NCBI
This chapter examines several genetic disorders that may underlie epilepsy and several neurodevelopmental disorders.
[70]
The Debate Over Sensory Processing - Child Mind Institute
Jan 21, 2025 · A look at the dispute over whether sensory symptoms constitute a disorder, and whether treatment works.
[71]
Internet Gaming Disorder in Children and Adolescents with Autism ...
Feb 2, 2024 · Internet gaming disorder (IGD) has been included by the American Psychiatric Association (APA) in the fifth edition of the Diagnostic and ...2. Materials And Methods · 3. Results · 4. Discussion
[72]
ASD and ADHD Comorbidity: What Are We Talking About? - PMC
Feb 28, 2022 · According to the scientific literature, 50 to 70% of individuals with autism spectrum disorder (ASD) also present with comorbid attention ...
[73]
Decomposition of phenotypic heterogeneity in autism reveals ...
Jul 9, 2025 · Here, we leverage broad phenotypic data for a large autism cohort to parse both genetic and phenotypic heterogeneity and identify robust ...
[74]
When to screen for developmental language disorder: a review of ...
Oct 16, 2025 · Based on existing evidence, 2.5 years is the earliest age at which DLD screening tools begin to demonstrate acceptable predictive performance.
[75]
CDC's Developmental Milestones | Learn the Signs. Act Early. | CDC
Skills such as taking a first step, smiling for the first time, and waving “bye bye” are called developmental milestones. Children reach milestones in how ...Missing: NIH core symptoms neurodevelopmental
[76]
Developmental Delay - StatPearls - NCBI Bookshelf
Delay in development occurs when the child fails to attain developmental milestones as compared to peers from the same population.Missing: core | Show results with:core
[77]
Developmental Delay in Children: Symptoms, Causes & Outlook
What are the symptoms of a developmental delay? · Delays in rolling over, sitting up, crawling and walking. · Trouble with fine motor skills. · Problems ...Missing: presentations | Show results with:presentations
[78]
Neurodevelopmental delay: Case definition & guidelines for data ...
Case definitions and guidelines for data collection, analysis, and presentation for neurodevelopmental delay as an adverse event following immunization.
[79]
Developmental Disability and Mental Delay: Understanding DSM-5
GDD refers to a significant delay in two or more areas of development, such as cognitive, motor, communication, social, and self-help skills.
[80]
Prevalence of neurodevelopmental disorders among US children ...
Nov 23, 2022 · The weighted prevalence of currently had NDDs was 8.5% (95% CI: 7.9–9.2%) for ADHD, 2.9% (95% CI: 2.6–3.4%) for ASD, 1.4% (95% CI: 1.2–1.7%) for ...
[81]
Atypical Sensory Processing in Neurodevelopmental Disorders
Jul 19, 2024 · Conclusions: Compared to other NDDs, ASDs more frequently have atypical sensory processing and appear to present a specific vulnerability in the ...
[82]
An update on anxiety in youth with autism spectrum disorders - PMC
A recent meta-analysis found that the prevalence of at least one anxiety disorder among children with ASD was 39.6%. Specific phobia (29.8%), obsessive- ...
[83]
Depression in Adults with Attention-Deficit/Hyperactivity Disorder ...
2006; Miller et al. 2007). Prevalence estimates of major depressive disorder (MDD) in samples of adults with ADHD range from 16 to 31 % (Wilens et al. 2008).
[84]
Neurodevelopmental Disorders Commonly Presenting with Sleep ...
There is a high prevalence of sleep disorders in AS, which is reported to be between 20 and 80% [112]. Sleep disturbance is more common in individuals with ...
[85]
The complex interplay between autism spectrum disorder and gut ...
Sep 13, 2024 · The goal of this review is to explore potential link between gut microbiota and ASD in children, based on the recently available data.Missing: studies | Show results with:studies
[86]
Prevalence of epilepsy among people with intellectual disabilities
In general samples of people with intellectual disabilities, the pooled estimate from 38 studies was 22.2% (95% CI 19.6-25.1). Prevalence increased with ...Missing: disorders | Show results with:disorders
[87]
Comparative Effects of Stimulant and Antipsychotic Medications on ...
Stimulant monotherapy may mitigate the risk of obesity, while combined stimulant and antipsychotic treatment may lead to problematic eating behaviors.
[88]
How Do Adults with Autism Spectrum Disorder Participate in ... - NIH
Apr 17, 2021 · International studies report rates up to 60% of unemployment for adults with ASD with and without intellectual disability (Hendricks, 2010; ...
[89]
Real-world evaluation of prevalence, cohort characteristics, and ...
Aug 9, 2025 · Additionally, these models could inform the development of integrated care plans that address multiple comorbidities simultaneously.
[90]
Estimating life expectancy and years of life lost for autistic people in ...
Nov 23, 2023 · Compared to US national mortality statistics, life expectancy was reduced by 6.1 years for autistic men, and by 12.3 years for autistic women.
[91]
Age effects on autism heritability and etiological stability of autistic ...
Jan 18, 2024 · Existing twin studies on autism, based predominantly on children (Ronald & Hoekstra, 2011), have consistently reported high heritability ...
[92]
Genetics of attention deficit hyperactivity disorder - PMC
The mean heritability across 37 twin studies of ADHD or measures of inattentiveness and hyperactivity is 74% (Fig. 1). A similar heritability estimate of around ...
[93]
CHD8 regulates neurodevelopmental pathways associated ... - PNAS
Truncating mutation of chromodomain helicase DNA-binding protein 8 (CHD8) represents one of the strongest known risk factors for autism spectrum disorder (ASD).Missing: prevalence | Show results with:prevalence<|separator|>
[94]
A Functional Genetic Link between Distinct Developmental ...
We went on to demonstrate that variants of CNTNAP2 are associated with deficits in common forms of language impairment. In so doing, we provide an example of ...
[95]
Clinical Characterization of Copy Number Variants Associated With ...
Jan 26, 2022 · Among 24 877 individuals, the prevalence of 64 NDD CNVs was 2.5% (n = 627), with prevalence varying by locus, corroborating the presence of ...
[96]
Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials
In total, 95% of Rett syndrome cases are due to mutations in the MECP2 gene, an X-linked gene that encodes for the methyl CpG binding protein, a regulator of ...
[97]
Genetics of tuberous sclerosis complex: implications for clinical ...
Dec 21, 2016 · Neurological features include epilepsy, autism, and intellectual disability. There are more than 1,500 known pathogenic variants for TSC1 and ...
[98]
Polygenic and developmental profiles of autism differ by age at ...
Oct 1, 2025 · In independent cohorts of autistic individuals, common genetic variants account for approximately 11% of the variance in age at autism diagnosis ...
[99]
Maternal smoking during pregnancy as an environmental risk factor ...
A pooled odds ratio indicates more than a two-fold increase in risk for a diagnosis of ADHD in those individuals whose mothers smoked during pregnancy (odds ...Missing: 2- | Show results with:2-
[100]
Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders
May 15, 2024 · Up to 1 in 20 US school-aged children may have fetal alcohol spectrum disorders (FASDs). People with FASDs can experience lifelong issues.Prevalence · Fas · What To Know
[101]
The Iodine Deficiency Disorders - Endotext - NCBI Bookshelf
Feb 6, 2018 · Severe iodine deficiency in utero causes a condition characterized by gross mental retardation along with varying degrees of short stature, deaf ...
[102]
Folic Acid Supplementation to Prevent Neural Tube Defects ... - NCBI
High levels of folic acid supplementation (4 mg) have been found to reduce the risk of recurrent NTDs by more than 70 percent, and even more modest levels of ...
[103]
The Elusive Etiology of Autism: Nature and Nurture? - PMC
In 1999, “quasi-autistic” traits were described in up to 12% of Romanian orphans exposed to severe deprivation, who were later adopted in the UK, with symptoms ...
[104]
A second look at the development of Romanian orphanage children
Aug 5, 2025 · Previous research has shown that 30% of these Romanian orphans had multiple serious developmental problems and a much greater proportion had a ...
[105]
Associations between abuse/neglect and ADHD from childhood to ...
Children exposed to moderate abuse/neglect had higher odds of 2.02 for meeting diagnostic criteria for ADHD compared to children who were not exposed, while ...
[106]
Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR)
The manual will help clinicians and researchers define and classify mental disorders, which can improve diagnoses, treatment, and research.About DSM-5-TR · Updates to DSM Criteria, Text · Anxiety Disorders · Fact Sheets
[107]
ICD-11
ICD-11. International Classification of Diseases 11th Revision. The global standard for diagnostic health information. Use ICD‑11. ICD-11 Browser; for seeing ...WHO-FIC Maintenance Platform · Coding Tool · ICD-11 Training Package · ICD-API
[108]
The reclassification of neurodevelopmental disorders in ICD-11
Oct 1, 2025 · Developmental disorders have a high degree of overlap and comorbidity. This article summarizes the conceptual changes in ICD-11 compared to ICD ...Missing: 2022 | Show results with:2022
[109]
Clinical Screening for Autism Spectrum Disorder - CDC
Apr 15, 2025 · Modified Checklist for Autism in Toddlers (M-CHAT™) Parent-completed questionnaire designed to identify children at risk for autism in the ...
[110]
Cultural Issues Related to ICD-11 Mental, Behavioural and ...
Both ICD-11 and DSM-5 accept that culture plays an important role in the distress, perceptions, coping, support and help-seeking for all patients. Efforts were ...
[111]
https://icd.who.int/
[112]
Utility of the Ages and Stages Questionnaire to Identify ...
Aug 29, 2022 · A common screening tool is the Ages and Stages Questionnaire (ASQ), a parent-completed questionnaire at ages 1 to 66 months. It consists of ...
[113]
Screening for autism spectrum disorders with the social ... - PubMed
The Social Communication Questionnaire (SCQ) is a parent report screening measure for autism spectrum disorders (ASDs) based on the Autism Diagnostic Interview ...
[114]
(ADOS®-2) Autism Diagnostic Observation Schedule, Second Edition
Allows you to accurately assess and diagnose autism spectrum disorders (ASDs) across age, developmental level, and language skills.
[115]
What Is the Conners Rating Scale for ADHD? - WebMD
Jan 15, 2025 · The Conners rating scale is a questionnaire that asks about things like behavior, work or schoolwork, and social life.
[116]
Systematic review of MRI findings in children with developmental ...
To summarize the reported rates of magnetic resonance imaging (MRI) abnormalities in children with isolated global developmental delay (GDD) or intellectual ...Missing: frequency | Show results with:frequency
[117]
Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children ...
Apr 12, 2021 · In this systematic scoping review, we found convincing evidence of ADHD overdiagnosis and overtreatment in children and adolescents.
[118]
Families' and clinicians' experiences with telehealth assessments for ...
Jul 29, 2025 · Ultimately, telehealth can reduce the gap of care by expanding access and improving efficiency through early screening and assessment of ...Missing: post- | Show results with:post-
[119]
https://www.webmd.com/add-adhd/childhood-adhd/conners-rating-scale
[120]
Early intensive behavioral intervention (EIBI) for young children with ...
The aim of this review was to find out whether early intensive behavioral intervention (EIBI) can improve functional behaviors and skills, reduce the severity ...Missing: starting | Show results with:starting
[121]
A Meta-Analysis of Applied Behavior Analysis-Based Interventions ...
May 16, 2025 · This meta-analysis aimed to provide an updated examination of the effectiveness of ABA-based interventions in improving communication and ...
[122]
Determining Associations Between Intervention Amount and ...
Jun 24, 2024 · This meta-analysis investigates if the amount of intervention provided to young autistic children is associated with improved child ...
[123]
A follow-up study of early intensive behavioral intervention program ...
Jan 2, 2023 · We examined the sustained effects of early intensive behavioral intervention (EIBI) on 66 children with autism spectrum disorder who participated in the Future ...
[124]
CBT Success Rate Statistics: Effectiveness of CBT in 2024
Nov 7, 2024 · A meta-analysis of 64 studies found that iCBT was as effective as face-to-face CBT for depression and anxiety disorders, with a pooled effect ...
[125]
Effectiveness of cognitive behavioural‐based interventions for adults ...
Feb 16, 2023 · This meta-analysis indicates that CBT for adults with ADHD was effective in reducing both core and emotional symptoms.
[126]
[PDF] An Examination of Inclusive Education Programs for Children with ...
Aug 1, 2025 · Research consistently demonstrates that inclusive settings benefit both students with disabilities and their typically developing peers, yet ...Missing: neurodevelopmental disorders boost
[127]
[PDF] The Advantages and Challenges of Inclusive Education - ERIC
Mar 1, 2024 · Inclusive education integrates individuals with disabilities into regular classrooms, aiming for equal opportunities, but faces challenges like ...
[128]
ADHD in adults: Atomoxetine and stimulants are best for managing ...
Dec 20, 2024 · Using these short term data, the researchers found that at 12 weeks atomoxetine and stimulants were most effective at reducing core ADHD ...
[129]
[PDF] 20-272S065 Risperidone Clinical CTDL PREA - FDA
Jul 22, 2012 · Risperidone was the first drug approved for treatment of irritability associated with autistic disorder. There are no approved to treat the core ...
[130]
fda approval of risperidone gets mixed reviews from autism experts
Nov 7, 2006 · Risperidone was reported to be efficacious and safe for treating irritability, aggression, hyperactivity, and stereotypy in autistic children, ...
[131]
Effect of stimulants on final adult height - PMC - PubMed Central
Oct 5, 2022 · Previous studies have indicated that stimulant medications may suppress growth for a short period after treatment initiation; however, more ...
[132]
[PDF] Clinical Guidelines: - Community Behavioral Health
Feb 12, 2024 · Prescribers are encouraged to monitor heart rate (HR) and blood pressure (BP) in youth taking stimulant medication. Non-stimulant ADHD ...
[133]
First study to compare ketamine therapies for patients with severe ...
Sep 25, 2025 · IV ketamine showed greater overall efficacy, with a 49.22 percent reduction in depression scores by the final dose while IN esketamine resulted ...
[134]
Efficacy of parent–child interaction therapy for children born premature
Feb 26, 2024 · This study examined the effectiveness of parent–child interaction therapy (PCIT) in reducing behavioral problems in young children born premature.
[135]
Outcomes of Parent-Child Interaction Therapy (PCIT) for families ...
PCIT was an effective treatment in improving a variety of child and parent outcomes in this population including reduced parenting stress, child behavior ...
[136]
An ecological approach to caregiver burnout: interplay of self-stigma ...
Feb 18, 2025 · About 5–9% of parents experience caregiving burnout, with higher rates among parents of children with special needs (SN). Research shows that ...
[137]
Group-based caregiver support interventions for children living with ...
Apr 12, 2024 · Caregiver support group interventions provide a promising avenue of improving caregiver and child outcomes for children living with disability ...Missing: rates | Show results with:rates<|separator|>
[138]
Caregiver burden among caregivers of children with autism ... - NIH
Caregivers of children and adolescents with a diagnosis of ASD are mostly mothers and experience mild to moderate levels of caregiver burden.
[139]
Respite Care for Children with Disabilities | Navigate Life Texas
Mental health professionals and counselors recommend respite for parents of children with disabilities or special health care needs.Missing: vocational neurodevelopmental
[140]
Respite Services - Texana Center
These services are available to assist people with developmental disabilities in developing the skills they need to obtain competitive employment in the ...
[141]
Vocational Rehabilitation Program - Texas Workforce Commission
Our program helps people with disabilities get ready for, find, or keep a job. We help adults with disabilities of all ages. We also help young students.Adults · Vocational Rehabilitation... · Requirements for Vocational · VR Forms<|control11|><|separator|>
[142]
New WHO guidance calls for urgent transformation of mental health ...
Mar 25, 2025 · The guidance provides a clear framework to transform mental health services in line with the latest evidence and international human rights standards.
[143]
Autism Speaks: Autism support, resources & advocacy
Autism Speaks is dedicated to promoting solutions, across the spectrum and throughout the life span, for the needs of individuals with autism and families.Autism spectrum disorder (ASD) · About Autism Speaks · Contact us · Directory
[144]
What are ABLE Accounts? - ABLE National Resource Center
An ABLE account is a savings and / or investment option for people with disabilities who qualify. It falls under Section 529A of the Internal Revenue Service ...
[145]
ABLE accounts - Tax benefit for people with disabilities - IRS
Jul 22, 2025 · Funds from these 529A ABLE accounts can help designated beneficiaries pay for qualified disability expenses. Distributions are tax-free if used for qualified ...
[146]
Altered brain connections in youth with ADHD - NIH
Mar 26, 2024 · Youth with ADHD have elevated brain activity connecting the frontal cortex with the information processing centers deep in the brain.
[147]
Identifying ADHD‐Related Abnormal Functional Connectivity with a ...
Apr 30, 2024 · Our results suggest that the frontal, temporal, parietal, and cerebellar regions are likely the primary areas of dysfunction in individuals with ADHD.
[148]
Leveraging AI-Driven Neuroimaging Biomarkers for Early Detection ...
Jul 22, 2025 · Machine learning classifiers achieved high diagnostic accuracy (85-99%) using features derived from neural oscillatory patterns, connectivity ...
[149]
Preliminary perspectives on gene therapy in fragile X syndrome
Sep 1, 2025 · Although there are no gene therapy trials currently ongoing in FXS in humans, early phase trials are ongoing in other genetic neurodevelopmental ...Missing: CRISPR | Show results with:CRISPR
[150]
Enhancing the discriminatory power of polygenic scores for ADHD ...
Jun 9, 2025 · Polygenic scores (PGS) are widely used in psychiatric genetic associations studies due to their predictive power for focal outcomes.
[151]
Examining the role of common variants in rare neurodevelopmental ...
Nov 20, 2024 · In summary, there is evidence for direct genetic effects of the polygenic score for rare neurodevelopmental conditions, but not for polygenic ...
[152]
Research Publications - ABCD Study
Here, we assessed the ways and degree to which multi-system environmental factors during late childhood are associated with subcortical volume and ...
[153]
Relationships between brain activity, tryptophan-related gut ... - Nature
Apr 14, 2025 · Chen, Y.-C. et al. Altered gut microbiota correlates with behavioral problems but not gastrointestinal symptoms in individuals with autism.
[154]
Gut-Brain Axis: Understanding the Interlink Between Alterations in ...
Jul 23, 2025 · Children who have both ASD and GI disturbances showcase heightened anxiety, irritability, and social withdrawal compared with those without GI ...
[155]
Microbiota Gut-Brain Axis and Autism Spectrum Disorder - PubMed
Functional gastrointestinal disorders (FGIDs) are prevalent in ASD, linking gut-brain axis dysfunction to behavioral severity. Therapeutically, ...Missing: papers comorbidity
[156]
Angelman Syndrome Therapies Show Positive Results in Early ...
Sep 24, 2024 · Ionis plans to meet with the FDA to discuss the design for a Phase 3 study and hopes to begin testing in the first half of 2025. The results ...
[157]
Ultragenyx Completes Enrollment of Phase 3 Aspire Study ...
Jul 31, 2025 · Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome. July 31, 2025. PDF Version.
[158]
Details Surrounding Phase 3 Study of ION582 in Angelman ...
Nov 9, 2024 · Ionis Pharmaceuticals plans a phase 3 trial for ION582 in Angelman syndrome, starting in 2025, involving 200 participants. ION582 is an ...
[159]
Neural progenitor cell transplantation results in structural and ...
Neural progenitor cell transplantation results in structural and functional recovery in a rat model of cerebral palsy ... Iran J Basic Med Sci. 2025;28(9):1230- ...Missing: trials 2024 2026
[160]
Clinical trials and advanced MRI techniques with stem cell therapy ...
Oct 8, 2025 · Safety and efficacy outcomes after intranasal administration of neural stem cells in cerebral palsy: a randomized phase 1/2 controlled trial.
[161]
A systematic review and meta-analysis of randomized controlled trials
Aug 29, 2025 · Over fifteen years, stem cell transplantation has shown multiple potential benefits for the treatment of cerebral palsy [18]. Cell therapy may ...
[162]
Effects of immersive virtual reality training on the adaptive skills of ...
Conclusion: This pilot study supports IVR training as a feasible and potentially effective training method for improving adaptive skills in children and ...
[163]
Effectiveness of Virtual Reality Technology Interventions in ...
Feb 5, 2025 · Our findings indicate that VR interventions have a positive effect on improving social skills in children and adolescents with ASD. Compared ...
[164]
Implementation of generative AI for the assessment and treatment of ...
Generative artificial intelligence (GenAI) offers emerging opportunities for automatically assisting and personalizing ASD care.
[165]
Leveraging and Harnessing Generative Artificial Intelligence ... - MDPI
They will generate personalized therapeutic regimens by analyzing a child's comprehensive developmental profile, response history, and co-occurring conditions, ...
[166]
Prenatal detection of copy number variants - ScienceDirect.com
Identifying CNVs in prenatal testing allows for early intervention, personalised treatment plans, and informed decision-making for expectant parents. Most CNVs ...
[167]
Efficiency of Non-Invasive Prenatal Testing in Detecting Fetal Copy ...
Oct 4, 2024 · This study was designed to investigate the efficiency of non-invasive prenatal testing (NIPT) in detecting fetal CNVs.
[168]
Clinical application of CNV-seq for diagnosing abnormal brain ...
Sep 29, 2025 · An increasing body of evidence supports the application of CNV-seq in detecting chromosomal aberrations associated with neurodevelopmental ...